{
  "url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1994/schedule-1/part-III/paragraph-1",
  "json_url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1994/schedule-1/part-III/paragraph-1.json",
  "legislation": "uksi/1994/1554",
  "legislation_title": "The Medicines (Fees Relating to Medicinal Products for Animal Use) Regulations 1994",
  "legislation_url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1994",
  "path": "schedule/1/part/III/paragraph/1",
  "kind": "paragraph",
  "number": "1",
  "heading": "Product licences",
  "text": "(1) The fee for a complex application for variation of a product licence shall be £1,100.\n(2) The fee for an application for the variation of a product licence other than a complex application shall be in accordance with the following Table:\nKind of application\nFee payable\nVariation requiring veterinary, scientific or pharmaceutical assessment\n£340 for the first variation plus £140 for each additional consequential variation to other licences in identical terms\nVariation not requiring veterinary, scientific or pharmaceutical assessment\n£140\nVariation involving the re-issue of the licence in the new name of the company\n£140\nVariation where the product licence relates solely to an emergency vaccine\n£40",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1994/1554/schedule/1/part/III/paragraph/1",
    "retrieved_at": "2026-10-29T13:31:23.554731+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}